|
| Exchange Received Time 14/08/2018 20:54:42 Exchange Disseminated Time 14/08/2018 20:54:47 Time Taken 00:00:05 | to acquire a majority stake in Global Allied Pharmaceuticals Private Limited (Gapsos, www.gapsos.in) providing Life Science Technology Services in the area of Clinical data management and analytics, Clinical Data Warehousing and Pharmacovigilance. presently, Gapsos operates over 10 countries including USA, Brazil, Mexico, Russia, France, Japan and China. This acquisition makes Calsoft as global leadership in the space of Life Science Technology. This acquisition is subject to satisfactory completion of due-diligence.
to Setting up verticals in the area of Life Science Technology, E Commerce, Loyalty program management, Artificial Intelligence (AI) and Big- Data Analysis, in this regard Board further approves for setting up 100% subsidiaries in USA, Canada, Europe and Middle East.
un-audited financial results of the Company for the quarter ended 30th June 2018
the notice convening the Annual General Meeting of the Company to be held on Saturday, September 29, 2018.
|
|
|